Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)

Clinical trial NCT03885934 · COMPLETED

Trial details

NCT number: NCT03885934
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2019-06-25
Primary completion: 2020-12-09
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.